Literature DB >> 17967931

Expression of hepatic UDP-glucuronosyltransferase 1A1 and 1A6 correlated with increased expression of the nuclear constitutive androstane receptor and peroxisome proliferator-activated receptor alpha in male rats fed a high-fat and high-sucrose diet.

Makoto Osabe1, Junko Sugatani, Tomoaki Fukuyama, Shin-ichi Ikushiro, Akira Ikari, Masao Miwa.   

Abstract

Rats that consumed a high-fat and high-sucrose (HF1) diet or a high-fat (HF2) diet developed hepatic steatosis. The alteration in nutritional status affected hepatic cytochrome P450 and UDP-glucuronosyltransferase (UGT) levels. Messenger RNA and protein levels of UGT1A1 and UGT1A6 in the liver but not the jejunum were increased in male rats fed the HF1 diet. These protein levels did not increase in HF2-fed male rats or HF1-fed female rats. In contrast, the CYP1A2 protein level was decreased in the HF1 but not HF2 diet group, whereas CYP2E1 and CYP4A protein levels were elevated in the HF2 but not HF1 diet group. No significant difference in the organic anion transporter polypeptide (Oatp) 1, Oatp2, multidrug resistance-associated protein (Mrp) 2, or Mrp3 protein levels was found between the standard and HF1 diet groups of male rats. Consumption of the HF1 diet affected the in vivo metabolism of acetaminophen (APAP) such that the area under the APAP-glucuronide plasma concentration-time curve was elevated 2.1-fold in male rats but not female rats. In liver cell nuclei of male rats but not female rats, constitutive androstane receptor (CAR) and proliferator-activated receptor alpha (PPARalpha) protein levels were significantly enhanced by intake of the HF1 diet. Additionally, administration of the PPARalpha agonist clofibrate to male rats up-regulated UGT1A1 and UGT1A6 and down-regulated CYP1A2 in the liver. Taken together, these results indicate that nutritional status may gender-specifically influence the expression and activation of CAR and PPARalpha in liver cell nuclei, and this effect appears to be associated with alterations in UGT1A1 and UGT1A6 expression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17967931     DOI: 10.1124/dmd.107.017731

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  26 in total

Review 1.  Role of CYP2E1 in Mitochondrial Dysfunction and Hepatic Injury by Alcohol and Non-Alcoholic Substances.

Authors:  Mohamed A Abdelmegeed; Seung-Kwon Ha; Youngshim Choi; Mohammed Akbar; Byoung-Joon Song
Journal:  Curr Mol Pharmacol       Date:  2017       Impact factor: 3.339

2.  The role of nuclear receptors in the kidney in obesity and metabolic syndrome.

Authors:  Claudia Tovar-Palacio; Nimbe Torres; Andrea Diaz-Villaseñor; Armando R Tovar
Journal:  Genes Nutr       Date:  2012-04-25       Impact factor: 5.523

3.  Role of high-fat diet in regulation of gene expression of drug metabolizing enzymes and transporters.

Authors:  Romi Ghose; Ozozoma Omoluabi; Adarsh Gandhi; Pranav Shah; Kelley Strohacker; Katie C Carpenter; Brian McFarlin; Tao Guo
Journal:  Life Sci       Date:  2011-05-18       Impact factor: 5.037

4.  A high-fat high-sucrose diet affects the long-term metabolic fate of grape proanthocyanidins in rats.

Authors:  Eunice Molinar-Toribio; Elisabet Fuguet; Sara Ramos-Romero; Núria Taltavull; Lucía Méndez; M Rosa Nogués; Isabel Medina; Josep Lluís Torres; Jara Pérez-Jiménez
Journal:  Eur J Nutr       Date:  2016-10-12       Impact factor: 5.614

Review 5.  Role of xenobiotics in the induction and progression of fatty liver disease.

Authors:  James E Klaunig; Xilin Li; Zemin Wang
Journal:  Toxicol Res (Camb)       Date:  2018-05-18       Impact factor: 3.524

Review 6.  Drug metabolism alterations in nonalcoholic fatty liver disease.

Authors:  Matthew D Merrell; Nathan J Cherrington
Journal:  Drug Metab Rev       Date:  2011-05-25       Impact factor: 4.518

7.  UDP-glucuronosyltransferase expression in mouse liver is increased in obesity- and fasting-induced steatosis.

Authors:  Jialin Xu; Supriya R Kulkarni; Liya Li; Angela L Slitt
Journal:  Drug Metab Dispos       Date:  2011-10-26       Impact factor: 3.922

Review 8.  Regulation of hepatic ABCC transporters by xenobiotics and in disease states.

Authors:  Xinsheng Gu; Jose E Manautou
Journal:  Drug Metab Rev       Date:  2010-08       Impact factor: 4.518

9.  A HPLC-Q-TOF-MS-based urinary metabolomic approach to identification of potential biomarkers of metabolic syndrome.

Authors:  Zhi-Rui Yu; Yu Ning; Hao Yu; Nai-Jun Tang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-04-08

10.  Comparison of enzymatically synthesized inulin, resistant maltodextrin and clofibrate effects on biomarkers of metabolic disease in rats fed a high-fat and high-sucrose (cafeteria) diet.

Authors:  Junko Sugatani; Makoto Osabe; Tadashi Wada; Kasumi Yamakawa; Yasuhiro Yamazaki; Tadanobu Takahashi; Akira Ikari; Masao Miwa
Journal:  Eur J Nutr       Date:  2008-06-16       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.